A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis - Concepedia

Concepedia

Publication | Open Access

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis

DOI Full Paper Access

105

Citations

13

References

2013

Year

Melvin Churchill, Luis Felipe Flores-Suárez, Mario H. Cardiel, Daniel J. Wallace, Richard W. Martin, Kristine Phillips, Jeffrey Kaine, Hua Dong, David H. Salinger, Erin Stevens,

Arthritis Research & Therapy

Abstract

ClinicalTrials.gov, NCT00771030.

References

	Year	Citations

Page 1